A new biological cleaner using protolytic enzymes that is designed for decontamination of medical, surgical, dental and endoscopic instruments.

Viruzyme does not contain any hazardous aldehydes or chlorine generating components.

This formulation is a highly effective and safe process for the cleaning of endoscopes, medical, dental and delicate instruments against a wide range of contaminants.

Viruzyme is particularly effective for the removal of protein and organic contaminants from surfaces, including dried on blood and tissue.

Viruzyme is registered as a Class I medical Device.

It is safe to use on any surface and offers particular benefits where autoclave decontamination cannot be used, e.g. optic probes. It has an effective cleaning action during cold water pre-rinse stages of automated washer/disinfector equipment, and does not interfere with the cleaning mechanism in ultrasonic and washer/disinfector equipments.



Primary features attributable to Viruzyme are:

• Biological cleaner suitable for removal of proteinaceous and organic contaminants from sensitive instrument materials;

• Uses a blend of protolytic enzymes that have added safety:

1. Low toxicity

2. Odourless;

3. Reduced instrument damage and repair;

4. Excellent material compatibility;

5. Non-fixative;

6. Non-corrosive, will not damage delicate coatings;

7. Increased speed and efficiency;

8. Rapid reaction time – 5 minute immersion at 20 to 30 ºC;

9. Improved instrument availability through faster turn around times for decontamination;

10. Cost effective – improved staff productivity, more flexible, more devices processed per litre.


 File NameSizeModified
Viruzyme-new-eu-V2.1-Aug-22.pdf249.3 KB08/06/2023
Viruzyme-2021.pdf555.6 KB13/06/2023
Viruzyme-INF-V3.4-Feb-24.pdf215.7 KB07/03/2024


    For more information about this product please complete the form below and we will be in touch.

    Full Name *

    Email *

    Contact Telephone

    Organisation *


    Input this code: captcha


    I agree to Amity International Privacy Policy*